Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Audentes Therapeutics Inc
BOLD | US
3.03
USD-0.02
-0.66%
BOLD | US
About Audentes Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
3.03
Open
2.94
High
3.08
Low
2.94
View Less
BOLD | US
Risk
72.9
Sharpe
0
Luna's Score
46/100
Recommendation
Hold
Luna says (BOLD | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Weakness based on declining price with high volume
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
35.8%1 month
72.9%3 months
92.0%6 months
103.9%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.45
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-64.01M
MarketCap
79.37M
MarketCap(USD)
79.37M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-35.74
Short ratio
10.24
Short perc.
4.34
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.43
Range1M
1.67
Range3M
1.87
Volumes: Market Activity
Rel. volume
1.41
Price X volume
219.61K
